Investor Relations January 23, 2025 Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23 Read More
Investor Relations January 14, 2025 Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 Read More
Investor Relations December 23, 2024 Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic Read More
Investor Relations November 26, 2024 New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market Read More
Investor Relations November 1, 2024 Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th Read More
Investor Relations October 28, 2024 Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease Read More
